EUVIMEDSkopri EUVIMED
Video/Audio

Coupling Gemcitabine Quantification with Bioluminescence Imaging to Visualize Pharmacokinetic–Pharmacodynamic Relationships in Pancreatic Cancer Model

Xinyu Gao, Wenbin Wang, Ruiying Zhang, Xinyu Wang, Fangping Wu, Kaidi Chen, Mancang Gu

Journal of Visualized Experiments · 2026-11-05 · (237)

DOI: 10.3791/71298 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2026-11-05. Written by Xinyu Gao and 6 co-authors. Institution: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University. Major MEDLINE topics: Deoxycytidine, Pancreatic Neoplasms, Luminescent Measurements, Antimetabolites, Antineoplastic.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Gemcitabine is a first-line chemotherapeutic agent for pancreatic cancer, but its efficacy is frequently limited by rapid intracellular metabolism, insufficient retention, and transporter-mediated efflux. Although intracellular drug concentrations and antitumor responses can be evaluated separately, a visualized and quantitative strategy to dynamically relate intracellular drug exposure to functional responses across in vitro and in vivo models remains lacking. Here, an integrated workflow is described that combines established quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) and bioluminescence imaging (BLI) approaches to characterize intracellular gemcitabine exposure and treatment responses in pancreatic cancer models. LC-MS/MS is used to quantify intracellular gemcitabine and its inactive metabolite 2',2'-difluorodeoxyuridine (dFdU), enabling direct assessment of cellular drug exposure, metabolism, and retention. In parallel, luciferase-based BLI provides a noninvasive functional readout of viable tumor burden and treatment response in both cultured cells and xenograft models. By extracting PK parameters from LC-MS/MS measurements and PD-like parameters from time-resolved BLI signals, the workflow provides an operational framework for quantitatively linking intracellular drug exposure with imaging-derived responses. A two-step translational mapping strategy further connects intracellular exposure with in vitro BLI behavior and subsequently with in vivo BLI outcomes and tumor growth inhibition, thereby extending the analysis beyond parallel measurement of pharmacokinetics and pharmacodynamics. Using this workflow, Coix seed extract (CSE) is shown to prolong intracellular gemcitabine retention and enhance antitumor efficacy. The methodological contribution of this protocol lies in the integration of established LC-MS/MS and BLI measurements into a unified workflow and the implementation of cross-system translational mapping, rather than in the development of either analytical technology itself. The integrated workflow provides a visualized and quantitative approach for relating intracellular drug exposure to functional imaging responses and whole-animal treatment outcomes. The workflow may provide a practical framework for evaluating chemosensitizers, transporter modulators, and anticancer agents in translational pharmacology and cancer drug development.

Subjects

MeSH terms (MEDLINE)

DeoxycytidinePancreatic NeoplasmsLuminescent MeasurementsAntimetabolites, AntineoplasticGemcitabineAnimalsHumansMiceTandem Mass SpectrometryCell Line, TumorLiquid Chromatography-Mass Spectrometry

Substances

DeoxycytidineGemcitabineAntimetabolites, Antineoplastic

Authors and institutions

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University.
  • School of Basic Medical Sciences, Guangzhou University of Chinese Medicine.
  • Jinhua Academy of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University; 202011113511009@zcmu.edu.cn.
  • Jinhua Academy of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University.
  • Institute for Innovation in Modern Traditional Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University; gmancang@zcmu.edu.cn.

Cite

APA

Gao, X., Wang, W., Zhang, R., Wang, X., Wu, F., Chen, K., & Gu, M. (2026). Coupling Gemcitabine Quantification with Bioluminescence Imaging to Visualize Pharmacokinetic–Pharmacodynamic Relationships in Pancreatic Cancer Model. Journal of Visualized Experiments. https://doi.org/10.3791/71298

Vancouver

Gao X, Wang W, Zhang R, Wang X, Wu F, Chen K, et al. Coupling Gemcitabine Quantification with Bioluminescence Imaging to Visualize Pharmacokinetic–Pharmacodynamic Relationships in Pancreatic Cancer Model. Journal of Visualized Experiments. 2026. doi:10.3791/71298

BibTeX
@article{Gao2026,
  author = {Gao, Xinyu and Wang, Wenbin and Zhang, Ruiying and Wang, Xinyu and Wu, Fangping and Chen, Kaidi and Gu, Mancang},
  title = {Coupling Gemcitabine Quantification with Bioluminescence Imaging to Visualize Pharmacokinetic–Pharmacodynamic Relationships in Pancreatic Cancer Model},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {237},
  doi = {10.3791/71298}
}
Start for free →